Lincoln Pharma: Value and Growth StocksAug 17, 2015
Lincoln Pharma looks like ready to trade higher. Its financials are improving and recently it has launched extended release oral suspension drugs which is cough syrup. It is a dividend paying company.
Promoters stake has increased by 3.88%.
Improved Credit rating in Nov, 2014. A3+.
CMP: Rs 127.